ROGER SAMUEL: Open Payments
NPI 1033207741 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 28 payments from 9 companies in 2025. Trend: 2023 $551 · 2024 $719 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $165 |
| Neurocrine BioSciences, Inc. | 5 | $143 |
| Alkermes, Inc. | 4 | $89 |
| Bausch Health US, LLC | 4 | $86 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
Products named: INGREZZA, HETLIOZ, APLENZIN, FANAPT, LYBALVI, Auvelity, TRINTELLIX, CAPLYTA.
Industry payments across FL — which companies pay providers there.
